Essity AB (publ) (ETTYF)
| Market Cap | 20.06B +14.3% |
| Revenue (ttm) | 14.19B -4.0% |
| Net Income | 1.25B -1.4% |
| EPS | 1.83 +0.3% |
| Shares Out | n/a |
| PE Ratio | 16.05 |
| Forward PE | 14.07 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 100 |
| Open | 28.80 |
| Previous Close | 28.35 |
| Day's Range | 28.80 - 28.80 |
| 52-Week Range | 24.80 - 29.99 |
| Beta | 0.37 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Jul 16, 2026 |
About Essity AB
Essity AB (publ) develops, produces, and sells hygiene and health products and services in Europe, North and Latin America, Asia, and internationally. The company operates through three segments: Health & Medical, Consumer Goods, and Professional Hygiene. The Health & Medical segment offers incontinence products, wound care, compression therapy, orthopedics, skincare products, and digital solutions with sensor technology under the TENA, Leukoplast, JOBST, Actimove, Cutimed, Delta-Cast, AquaCast Liner, and Hydrofera brands to family carers, prof... [Read more]
Financial Performance
In 2025, Essity AB's revenue was 138.49 billion, a decrease of -4.85% compared to the previous year's 145.55 billion. Earnings were 12.66 billion, a decrease of -39.41%.
Financial numbers in SEK Financial StatementsNews
Essity downgraded to Sell from Neutral at Goldman Sachs
Goldman Sachs downgraded Essity (ETTYF) to Sell from Neutral with a SEK 255 price target The firm sees downside risk to consensus estimates, saying the company’s pricing continues to lag…
Essity AB Earnings Call Transcript: Q2 2026
Q2 2026 saw positive organic sales growth, strong volumes in most segments, and resilient margins despite cost inflation. Price increases and cost-saving programs are underway to offset higher COGS, with further margin improvement expected as integration and innovation continue.
Essity AB Quarterly report: Q2 2026
Essity AB has published its Q2 2026 quarterly earnings report on July 16, 2026.
Essity AB Slides: Q2 2026
Essity AB has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on July 16, 2026.
Essity Earnings Fall In Q2
(RTTNews) - Essity AB (ESSITY-B.ST, ESSITY-A.ST), a hygiene and health company, on Thursday reported lower net income in the second quarter of 2026 compared with the prior year, despite higher sales, ...
Essity AB Transcript: 23rd annual dbAccess Global Consumer Conference
Leadership is accelerating strategy execution with a decentralized structure, portfolio review, and cost-saving initiatives. Business units focus on high-value segments, innovation, and resilience, with price increases and reinvestment in growth to navigate current market challenges.
Essity AB Transcript: CMD 2026
A strategic review of the Consumer Tissue business is underway, with a focus on shifting the portfolio toward higher value-added segments and accelerating profitable growth. Clear financial targets and cost-saving initiatives support increased investment in innovation, digitalization, and sustainability, while each business area pursues tailored growth strategies.
Essity AB Press release: FY 2026
Essity AB issued a press release on May 7, 2026, disclosing material business information to investors.
Essity AB Slides: FY 2026
Essity AB has posted slides in relation to its FY 2026 quarterly earnings report, which was published on May 7, 2026.
Essity AB Earnings Call Transcript: Q1 2026
Organic sales and volume growth, improved margins, and strong cash flow marked Q1 2026, supported by a major North American acquisition and a SEK 3 billion share buyback. Input cost inflation and selective price increases are expected to shape results in H2.
Essity AB Quarterly report: Q1 2026
Essity AB has published its Q1 2026 quarterly earnings report on April 23, 2026.
Essity AB Slides: Q1 2026
Essity AB has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on April 23, 2026.
Essity downgraded to Underweight from Neutral at JPMorgan
JPMorgan downgraded Essity (ETTYF) to Underweight from Neutral with a price target of SEK 215, down from SEK 245. The firm says the company is facing pressure from higher pulp…
Essity price target lowered to SEK 290 from SEK 315 at UBS
UBS analyst Charles Eden lowered the firm’s price target on Essity (ETTYF) to SEK 290 from SEK 315 and keeps a Buy rating on the shares.
Essity AB Slides: FY 2026
Essity AB has posted slides in relation to its FY 2026 quarterly earnings report, which was published on March 26, 2026.
Essity price target lowered to SEK 247 from SEK 252 at Jefferies
Jefferies analyst David Hayes lowered the firm’s price target on Essity (ETTYF) to SEK 247 from SEK 252 and keeps a Hold rating on the shares. The firm estimates the…
Essity price target lowered to SEK 225 from SEK 235 at Deutsche Bank
Deutsche Bank lowered the firm’s price target on Essity (ETTYF) to SEK 225 from SEK 235 and keeps a Sell rating on the shares.
Invitation to presentation of Essity's interim report for quarter 1, 2026
STOCKHOLM, March 23, 2026 /PRNewswire/ -- The hygiene and health company, Essity, will publish its interim report for quarter 1, 2026 on April 23 at approximately 07:00 CET. President and CEO Ulrika K...
Essity price target lowered to SEK 245 from SEK 260 at JPMorgan
JPMorgan analyst Celine Pannuti lowered the firm’s price target on Essity (ETTYF) to SEK 245 from SEK 260 and keeps a Neutral rating on the shares.
Essity AB Transcript: UBS Global Consumer and Retail Conference
Strong brands and innovation drive growth in high-margin hygiene and health categories, supported by a decentralized structure and targeted acquisitions. Cost-saving programs and digital transformation underpin efficiency, while disciplined capital allocation supports dividends and buybacks.
Essity AB Slides: UBS Global Consumer and Retail Conference
Essity AB has posted slides in relation to its latest quarterly earnings report, which was published on March 12, 2026.
Essity price target lowered to SEK 252 from SEK 253 at Jefferies
Jefferies lowered the firm’s price target on Essity (ETTYF) to SEK 252 from SEK 253 and keeps a Hold rating on the shares. The firm, which updated estimates following FY25…
Edgewell Personal Care completes sale of feminine care business for $340M
Edgewell Personal Care Company (EPC) completed the sale of its feminine care business to Essity (ETTYF) for $340M. Edgewell intends to use the net proceeds from the sale, after taxes…
Essity downgraded to Hold from Buy at Pareto
Pareto analyst Alexander Vilval downgraded Essity (ETTYF) to Hold from Buy with a SEK 270 price target
Essity AB Earnings Call Transcript: Q4 2025
Profit margins improved across all business areas in Q4 2025, despite negative organic sales growth due to price reductions. Strategic acquisitions, strong cash flow, and product innovation supported market share gains and a proposed 6% dividend increase.